These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14295594)

  • 1. [VALUE OF THE USE IN OPHTHALMOLOGY OF AN OINTMENT COMBINING NEOMYCIN AND TRIAMCINOLONE ACETONIDE].
    MOREAU PG; COURVOISIER F
    Bull Soc Ophtalmol Fr; 1964 Apr; 64():466-7. PubMed ID: 14295594
    [No Abstract]   [Full Text] [Related]  

  • 2. CLINICAL EXPERIENCE WITH OPHTHALMIC FORMULATIONS OF TRIAMCINOLONE ACETONIDE.
    HUGHES WL; KAZDAN MS; MARIS CS
    Am J Ophthalmol; 1965 May; 59():811-4. PubMed ID: 14288920
    [No Abstract]   [Full Text] [Related]  

  • 3. THE MANAGEMENT OF OCULAR INFLAMMATION WITH TRIAMCINOLONE ACETONIDE.
    CHALKLEY TH
    Am J Ophthalmol; 1965 May; 59():815-9. PubMed ID: 14288921
    [No Abstract]   [Full Text] [Related]  

  • 4. [VALUE OF A NEOMYCIN-TRIAMCINOLONE COMBINATION IN LOCAL APPLICATIONS].
    LAUGIER P
    Bull Soc Fr Dermatol Syphiligr; 1963; 70():489. PubMed ID: 14079100
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Kenacort-A ointment ophthalmic on ocular diseases].
    TOKUDA H
    Rinsho Ganka; 1961 Oct; 15():1085-7. PubMed ID: 13921589
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of triamcinolone acetonide phosphate and a combination with neomycin and gramicidin in ophthalmology].
    Leite Filho M
    Folha Med; 1965 Jul; 51(1):13-20. PubMed ID: 5857074
    [No Abstract]   [Full Text] [Related]  

  • 7. [VALUE IN DERMATOLOGY OF AN OINTMENT COMBINING KANAMYCIN AND TRIAMCINOLONE (KANAMYLONE)].
    BAZEX A; DUPRE A; CHRISTOL B
    Toulouse Med; 1963 Dec; 64():1121-30. PubMed ID: 14099358
    [No Abstract]   [Full Text] [Related]  

  • 8. [COMPARATIVE STUDIES ON EXTERNAL CORTICOSTEROIDS. THE PRO AND CON OF THE ANTIBIOTIC ADDITIVE].
    SIMONS RD
    Hautarzt; 1964 Jun; 15():287-94. PubMed ID: 14234732
    [No Abstract]   [Full Text] [Related]  

  • 9. TOPICAL THERAPY WITH TRIAMCINOLONE ACETONIDE IN OPHTHALMOLOGY: A PRELIMINARY REPORT.
    AQUAVELLA JV; LESSER DY; STAM JJ; VONHEISE C
    Eye Ear Nose Throat Mon; 1965 Jan; 44():37-42. PubMed ID: 14220155
    [No Abstract]   [Full Text] [Related]  

  • 10. [A clinical report on Kenacort-A ophthalmic ointment].
    KINUKAWA K; ABE N
    Rinsho Ganka; 1962 Jan; 16():89-91. PubMed ID: 14456220
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy and tolerance of a preparation containing triamcinolone acetonide, nystatin and neomycin].
    Flati G; Cerroni L; Legge A
    Clin Ter; 1987 Nov; 123(3):185-9. PubMed ID: 2972479
    [No Abstract]   [Full Text] [Related]  

  • 12. Triamcinolone acetonide, neomycin and undecylenic acid in the treatment of dermatophytosis.
    Chang CM
    Taiwan Yi Xue Hui Za Zhi; 1967 Apr; 66(4):193-9. PubMed ID: 5234169
    [No Abstract]   [Full Text] [Related]  

  • 13. MAXITROL SUSPENSION AND OINTMENT: CLINICAL EVALUATION OF TWO NEW ANTIBIOTIC-STEROID PREPARATIONS.
    MAXWELL E; AIJIAN KM
    Curr Ther Res Clin Exp; 1964 Feb; 6():130-3. PubMed ID: 14135297
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic value of Kenacomb ointment and cream manufactured by Squibb].
    Staszewska H
    Przegl Dermatol; 1970; 57(1):85-8. PubMed ID: 5417330
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of ocular diseases with acetonyl triamcinolone associated with neomycin and gramicidin].
    Federmann I
    Rev Bras Med; 1966 Feb; 23(2):122-3. PubMed ID: 5932997
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical steroid treatment of ocular inflammation: effectiveness of triamcinolone acetonide hemisuccinate and neomycin.
    Taub RG
    Eye Ear Nose Throat Mon; 1969 Feb; 48(2):85-8. PubMed ID: 5763570
    [No Abstract]   [Full Text] [Related]  

  • 17. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent.
    Medansky RS; Bressinck R; Cole GW; Deeken JH; Ellis CN; Guin JD; Herndon JH; Lasser AE; Leibsohn E; Menter MA
    Cutis; 1988 Nov; 42(5):480-5. PubMed ID: 3058398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of acetonyl-triamcinolone hemisuccinate associated with neomycin and gramicidin in ophthalmology].
    UCHOA I; LEITE FILHO LA
    Hospital (Rio J); 1963 Jun; 63():1379-84. PubMed ID: 13995096
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials of a new ointment containing triamcinolone acetonide and neomycin].
    Chapuis JL; Dechelotte R
    Sem Ther; 1964 Apr; 40(4):255-7. PubMed ID: 5878795
    [No Abstract]   [Full Text] [Related]  

  • 20. The Role of Excipients in the Stability of Triamcinolone Acetonide in Ointments.
    van Heugten AJP; de Vries WS; Markesteijn MMA; Pieters RJ; Vromans H
    AAPS PharmSciTech; 2018 Apr; 19(3):1448-1453. PubMed ID: 29450828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.